PT84675B - Processo para a preparacao de sulfonamidas substituidas com um grupo heterociclico contendo azoto, uteis como agentes anti-arritmicos - Google Patents

Processo para a preparacao de sulfonamidas substituidas com um grupo heterociclico contendo azoto, uteis como agentes anti-arritmicos

Info

Publication number
PT84675B
PT84675B PT84675A PT8467587A PT84675B PT 84675 B PT84675 B PT 84675B PT 84675 A PT84675 A PT 84675A PT 8467587 A PT8467587 A PT 8467587A PT 84675 B PT84675 B PT 84675B
Authority
PT
Portugal
Prior art keywords
nitrogenic
preparation
group containing
arrhythmic agents
containing nitrous
Prior art date
Application number
PT84675A
Other languages
English (en)
Other versions
PT84675A (en
Inventor
Peter Edward Cross
John Edmund Arrowsmith
Geoffrey Noel Thomas
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of PT84675A publication Critical patent/PT84675A/pt
Publication of PT84675B publication Critical patent/PT84675B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/90Oxygen atoms with acyclic radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
PT84675A 1986-04-16 1987-04-14 Processo para a preparacao de sulfonamidas substituidas com um grupo heterociclico contendo azoto, uteis como agentes anti-arritmicos PT84675B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868609331A GB8609331D0 (en) 1986-04-16 1986-04-16 Anti-arrythmia agents

Publications (2)

Publication Number Publication Date
PT84675A PT84675A (en) 1987-05-01
PT84675B true PT84675B (pt) 1989-11-30

Family

ID=10596325

Family Applications (1)

Application Number Title Priority Date Filing Date
PT84675A PT84675B (pt) 1986-04-16 1987-04-14 Processo para a preparacao de sulfonamidas substituidas com um grupo heterociclico contendo azoto, uteis como agentes anti-arritmicos

Country Status (14)

Country Link
US (3) US4863948A (pt)
EP (1) EP0242173A1 (pt)
JP (1) JPS62255474A (pt)
KR (1) KR870010012A (pt)
AU (1) AU575745B2 (pt)
CA (1) CA1295616C (pt)
DK (1) DK195087A (pt)
FI (1) FI871635A7 (pt)
GB (1) GB8609331D0 (pt)
HU (1) HU198014B (pt)
IL (1) IL82205A (pt)
NZ (1) NZ219990A (pt)
PT (1) PT84675B (pt)
ZA (1) ZA872703B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
US4956382A (en) * 1987-02-07 1990-09-11 Pfizer Inc. Sulfonamide anti-arrhythmic agents
US5262413A (en) * 1989-06-26 1993-11-16 Sankyo Company, Limited Use of isoxazolin-3-one derivatives as antidepressants
US5217970A (en) * 1989-06-26 1993-06-08 Sankyo Company, Limited Use of isoxazolin-3-one derivatives as antidepressants
US5032604A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
US5112824A (en) * 1989-12-08 1992-05-12 Merck & Co., Inc. Benzofuran compounds as class III antiarrhythmic agents
US5215989A (en) * 1989-12-08 1993-06-01 Merck & Co., Inc. Nitrogen-containing heterocyclic compounds as class III antiarrhythmic agents
US5032598A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
GB9021056D0 (en) * 1990-09-27 1990-11-07 Pfizer Ltd Antiarrhythmic agents
FR2674524B1 (fr) * 1991-03-25 1993-05-21 Adir Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5198443A (en) * 1991-06-28 1993-03-30 Warner-Lambert Company Substituted 1,2,3,6-tetrahydropyridines as central nervous system agents
KR960007566A (ko) * 1994-08-19 1996-03-22 김정규 신규한 퀴놀릴아민 유도체, 그의 제조방법 및 항부정맥제로서의 용도
WO1997046532A1 (en) * 1996-06-03 1997-12-11 Boehringer Ingelheim Pharmaceuticals, Inc. 2-benzyl-4-sulfonyl-4h-isoquinolin-1,3-diones and their use as anti-inflammatory agents
GB9711220D0 (en) * 1997-05-30 1997-07-23 Isis Innovation Antiarrhythmic agents
CN1675180A (zh) * 2002-06-12 2005-09-28 住友制药株式会社 吲哚、吲唑和氮茚衍生物
PL383550A1 (pl) * 2007-10-15 2009-04-27 Uniwersytet Łódzki Nowe pochodne benzeno- i pirydopirydazynonów
US9745308B2 (en) * 2014-09-12 2017-08-29 Chiesi Farmaceutici S.P.A. Pyridazinone derivatives as phoshoinositide 3-kinases inhibitors

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR148F (pt) * 1962-01-24
US3478149A (en) * 1962-01-24 1969-11-11 Mead Johnson & Co Therapeutic compositions and methods employing sulfonamidophenethanolamines
FR4290M (pt) * 1964-06-05 1966-07-18
LU47776A1 (pt) * 1964-07-30 1966-07-13
US3574741A (en) * 1969-04-14 1971-04-13 Mead Johnson & Co Sulfonamidophenalkylamines
US3758692A (en) * 1969-04-14 1973-09-11 Mead Johnson & Co Ylamines sympathomimetic process and compositions employing sulfonamidophenalk
GB1263987A (en) * 1969-05-30 1972-02-16 Allen & Hanburys Ltd Phenethylamine derivatives
US3623623A (en) * 1969-09-05 1971-11-30 Reflex Corp Canada Ltd Childproof safety package
BE757005A (fr) * 1969-10-02 1971-04-02 Bristol Myers Co Phenethanolamines substituees et procede pour leur preparation
US4087541A (en) * 1975-03-06 1978-05-02 Boehringer Ingelheim Gmbh 2-(Aralkylaminoalkyl)phthalimidines
DD123741A5 (pt) * 1975-03-06 1977-01-12
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
DE2639291A1 (de) * 1976-09-01 1978-03-02 Thomae Gmbh Dr K Neue aryl-alkylamine
DE2639718C2 (de) * 1976-09-03 1987-03-05 Dr. Karl Thomae Gmbh, 7950 Biberach 1-[6,7-Dimethoxy-3,4-dihydro-2H-isochinolin-1-on-2-yl]-3-[N-methyl-N-(2-(3,4-dimethoxy-phenyl)-äthyl)-amino]-propan, dessen physiologisch verträgliche Säureadditionssalze und diese Verbindungen enthaltende Arzneimittel
CH645628A5 (en) * 1977-01-01 1984-10-15 Thomae Gmbh Dr K Phenylethylamines
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
FR2533563A1 (fr) * 1982-09-23 1984-03-30 Adir Nouveaux derives de la sulfonyluree, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
FR2541999B1 (fr) * 1983-03-04 1986-09-19 Bristol Myers Co Phenethanolamines et leurs utilisations
US4581370A (en) * 1983-07-12 1986-04-08 Schering A.G. Antiarrhythmic imidazoliums
EP0164865B1 (en) * 1984-05-04 1988-12-21 The Upjohn Company N-(aminoalkylphenyl)sulfonamides their preparation and therapeutic use
JPS61124941A (ja) * 1984-11-21 1986-06-12 Fuji Photo Film Co Ltd 加熱工程を有する画像形成方法
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
DE3623944A1 (de) * 1986-07-16 1988-02-11 Thomae Gmbh Dr K Neue benzolsulfonamido-indanylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
HU198014B (en) 1989-07-28
JPS62255474A (ja) 1987-11-07
CA1295616C (en) 1992-02-11
HUT44528A (en) 1988-03-28
FI871635A0 (fi) 1987-04-14
AU7144287A (en) 1987-12-10
ZA872703B (en) 1989-07-26
NZ219990A (en) 1989-08-29
GB8609331D0 (en) 1986-05-21
FI871635A7 (fi) 1987-10-17
KR870010012A (ko) 1987-11-30
US5114952A (en) 1992-05-19
IL82205A (en) 1991-05-12
US4863948A (en) 1989-09-05
PT84675A (en) 1987-05-01
EP0242173A1 (en) 1987-10-21
US4990509A (en) 1991-02-05
AU575745B2 (en) 1988-08-04
IL82205A0 (en) 1987-10-30
DK195087A (da) 1987-10-17
DK195087D0 (da) 1987-04-15

Similar Documents

Publication Publication Date Title
PT84675B (pt) Processo para a preparacao de sulfonamidas substituidas com um grupo heterociclico contendo azoto, uteis como agentes anti-arritmicos
BR8705634A (pt) Processo para preparar alquil-fenois sulfurados,superbaseados,com metal do grupo ii
PT82794B (pt) Processo para a preparacao de derivados de 3-fenil-4-cianopirrole uteis como microbicidas
PT83481B (pt) Processo para a preparacao de heteropolissacarideos de baixa viscosidade
PT86312A (pt) Processo para a preparacao de fibras superabsorventes
PT83389B (pt) Processo para a preparacao de derivados de sulfonilureia uteis como agentes anti-tumurais
PT84350B (pt) Processo para a preparacao de polimeros contendo amida alcoxilada/cationicamente modificada
PT82430B (pt) Processo para a preparacao de novos 2,5-diaril-tetra-hidrofuranos e de seus analogos uteis como antagonistas de factor de activacao de plaquetas
PT84144B (pt) Processo para a preparacao de sulfonamidas heterociclicas uteis como agente antialergicos e antitromboticos
PT89269A (pt) Processo para a preparacao de 2,5-diaril-tetra-hidrofuranos uteis como antagonistas do factor activador de plaquetas
BR8701045A (pt) Processo para a elaboracao de solucoes de amina aquosas
PT89570A (pt) Processo para a preparacao de novos compostos de 1,3-dicarbonilo ciclicos
BR8704625A (pt) Processo para a preparacao de composicao de revestimento
PT83548B (pt) Processo para a preparacao de piperazino-isotiazolonas com accao psicotropica
BR8707852A (pt) Polimero ramificado contendo grupo silila,processo para sua preparacao,agentes de cobertura a base do polimero bem como sua aplicacao
NO169969C (no) Vaskemiddelblanding i pastaform som inneholder en organisk syre, samt fremgangsmaate for fremstilling derav
PT95119A (pt) Processo para a preparacao de carbamatos benzazaciclicos, uteis como inibidores de colinesterase
BR8706408A (pt) Processo para a preparacao de aldeidos
PT87974A (pt) Processo para a preparacao de 1h-pirazole-1-alcanamidas uteis como agentes anti-arritmicos
PT83293A (pt) Processo para a preparacao de di-hidropiridina-2-hidroxiaminas uteis como medicamentos
BR8500540A (pt) Processo para a preparacao de 1,3,2-dioxaborinanos
BR8702314A (pt) Processo para producao de ureia ciclica
BR8704717A (pt) Processo para a preparacao de acidos piridino-2,3-dicarboxilicos
PT83799B (pt) Processo para a preparacao de novos 2,2'-bi-1h-imidazoles
PT84176B (pt) Processo para a preparacao de derivados de 2,6-dioxabiciclo {3.3.o7octano uteis como medicamentos

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19921130